HealthDecision has introduced a new breast cancer screening software tool to predict personalized risk in patients.
The company is engaged in the development of a medical software platform, including shared decision making (SDM) tools, to enable clear clinician-patient discussions.
The tool intensd to offer patients with a personalized risk analysis for developing breast cancer in the next 10 years, as well as benefits or harms associated with mammogram screening.
It has been developed by using 2013 WI Partnership Program grant provided by the UW Madison Department of Radiology.
HealthDecision has developed the tool with the support of multidisciplinary team, including members from surgery, engineering, psychology, communications, primary care, vascular surgery research and decision making.
According to the company, the risks associated with mammogram screening comprised of over-detection and the subsequent effects of anxiety and possible overtreatment with surgery, as well as radiotherapy and sometimes chemotherapy.
The company also produces three more SDM tools, including atrial fibrillation tool, cardiovascular risk tool and lung cancer screening tool.
HealthDecision founder Dr Jon Keevil said: "As news and usage of HealthDecision has spread, I am gratified to see clinicians reach out to us for creating additional SDM tools, including the breast care team at UW Health, with whom HealthDecision collaborated to create the Breast Cancer Screening tool.
“Survey data has shown higher satisfaction rates for both patients and doctors using HealthDecision, an important metric reviewed by administrators. In this era of patient-centered care, SDM tools are an important method of empowering patients to take ownership of their healthcare."
Image: HealthDecision founder Jon Keevil. Photo: courtesy of HealthDecision, LLC.